| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |